Medicine guide
Osseor
·
- Prescription status not stated
- Muscles, joints and bones
- Active substance
- Strontium ranelate
- Used in
- Muscles, joints and bones
- Made by
- Les Laboratoires Servier
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of severe osteoporosis in postmenopausal women at high risk for fracture to reduce the risk of vertebral and hip fractures. Treatment of severe osteoporosis in adult men at increased risk of fracture. The decision to prescribe strontium ranelate should be based on an assessment of the individual patient's overall risks.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Les Laboratoires Servier |
|---|---|
| Active substance | Strontium ranelate |
| Used in | Muscles, joints and bones |
| Classification | M05BX03 · Muscles, joints and bones |
| Authorised on | 2004-09-20 |
| Last updated by the regulator | 2020-05-19 |
| EMA product number | EMEA/H/C/000561 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.